Endoscopic Ultrasound Market - Global Forecast to 2029
商品番号 : SMB-74066
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年2月 |
| ページ数 | 307 |
| 図表数 | 407 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The endoscopic ultrasonography market is projected to reach USD 1.93 billion by 2029 from USD 1.37 billion in 2024, at a CAGR of 7.1% during the forecast period. The endoscopic ultrasonography market has had strong growth due to a number of factors such as the rising incidences of cancer, growing initiatives to develop healthcare infrastructure in underdeveloped regions, increasing preference for minimally invasive surgeries, and advancements in endoscopic procedures.
超音波内視鏡（EUS）市場は、予測期間中に年平均成長率 7.1% で成長し、2024 年の 13 億 7,000 万米ドルから 2029 年には 19 億 3,000 万米ドルに達すると予測されています。超音波内視鏡（EUS）市場は、がんの発生率上昇、発展途上地域での医療インフラ整備に向けた取り組みの拡大、低侵襲手術の選好の増加、内視鏡手術の進歩など、さまざまな要因により力強い成長を遂げています。
“By product type, endoscopes segment is expected to account for the largest share in the endoscopic ultrasonography market.”
The endoscopes segment accounted for the largest share of the endoscopic ultrasonography market in the forecast period. The increasing demand for minimally invasive procedures, coupled with advancements in technology enhancing precision and control, are significant drivers. Moreover, the rising prevalence of gastrointestinal disorders necessitates more efficient and accurate diagnostic and therapeutic procedures, further boosting the adoption of endoscopes. These factors collectively contribute to the growth potential for this segment within the market.
“Diagnostics segment, by type is expected to have the largest market share in the endoscopic ultrasonography market”
Based on type, the diagnostics segment is expected to dominate the endoscopic ultrasonography market due to the increasing demand for early and accurate detection of chronic diseases coupled with advancements in imaging technology, providing real-time visualization and high-resolution images. Moreover, rising adoption of EUS-guided fine needle aspiration procedures worldwide, driven by their minimally invasive nature and associated benefits like shorter recovery times and reduced post-operative complications have further boosted the growth in this segment, thereby indicating promising growth potential within the endoscopic ultrasonography market.
“The gastrointestinal disorders segment accounted the second-largest market share in the endoscopic ultrasonography market.”
By application, the gastrointestinal disorders segment accounted for the second-largest market share in the endoscopic ultrasonography market. This significant share can be attributed to the rising prevalence of gastrointestinal disorders such as gastric cancer, chronic pancreatitis, and pancreatic cancer. Moreover, the growing geriatric population which is more prone to gastrointestinal diseases increasingly demand for advanced diagnostic procedures. These factors’ all together play a significant role in propelling market growth.
“Hospitals segment of the endoscopic ultrasonography market is expected to have largest share.”
Based on end user, the hospitals segment of the endoscopic ultrasonography market is expected to hold the largest share during the forecast period owing to the factors like the availability of advanced infrastructure constituting broad range of advanced diagnostic and therapeutic techniques, coupled with skilled professionals like gastroenterologists and endoscopists. Moreover, hospitals serving as vital healthcare centers, continuously invest in innovative endoscopic ultrasonography devices to address evolving healthcare demands, thus propelling market growth.
“Asia Pacific to hold third largest market share in the endoscopic ultrasonography market during the forecast period.”
The Asia Pacific region accounted the third largest share in the endoscopic ultrasonography market in the forecast period. The growth is attributed to several factors, including the growing advanced healthcare infrastructure, widespread acceptance of innovative medical devices, and increasing healthcare expenditure in Asia Pacific region. Additionally, the ongoing enhancements in endoscopic technologies are anticipated to increase the demand for endoscopic ultrasonography devices in APAC region.
A breakdown of the primary participants (supply side) for the endoscopic ultrasonography market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
- By Designation: C-level–35%, Director Level- 45%, and Others–20%
- By Region: North America–40%, Europe–30%, Asia Pacific–20%, Latin America-5%, and Middle East & Africa-5%
Prominent players in the endoscopic ultrasonography market include Olympus Corporation (Japan), Medtronic (US), FUJIFILM Holdings Corporation (Japan), Boston Scientific Corporation (US), PENTAX Medical (Japan), Steris (Ireland), CONMED Corporation (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), Cook (US), Huaco Healthcare Technologies Co. Ltd.(China), SonoScape Medical Corp.(China), Endosound, Inc.(US), Limaca-Medical (Israel), Beijing ZKSK Technology Co., Ltd. (China), Kaigen Pharma Co., Ltd.(Japan), PIOLAX MEDICAL DEVICES, INC.(Japan), Micro-Tech Endoscopy (US), Shaili Endoscopy (India), Zhejiang Soudon Medical Technology Co., Ltd.(China), ENDO-FLEX GmbH. (Germany), Ace Medical Devices Pvt. Ltd. (India), Medi-Globe GmbH.(Arizona), Medorah Meditek Pvt. Ltd.(India), and InnerMedical Co., Ltd. (China).
Research Coverage:
The report analyzes the endoscopic ultrasonography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall endoscopic ultrasonography market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (increasing requirement for endoscopy procedures to diagnose and treat target diseases, rising incidence of gastrointestinal disorders and colorectal cancer, increased investments, funds, and grants by government bodies and other organizations, technological advancements in endoscopic ultrasonography devices), restraints (high costs of endoscopic ultrasonography procedures, and complications and limitations of endoscopic ultrasonography), opportunities (high market growth potential in emerging economies, and increasing preference for minimally invasive surgeries) and challenges (increasing number of product recalls).
- Market Penetration: It includes extensive information on products offered by the major players in the global the endoscopic ultrasonography market. The report includes various segments in product, type, application, end user and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global endoscopic ultrasonography market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the endoscopic ultrasonography market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global endoscopic ultrasonography market.
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD 30
1.3.2 INCLUSIONS & EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 31
1.3.4 CURRENCY CONSIDERED 32
1.4 STAKEHOLDERS 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key sources of secondary data 34
2.1.1.2 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
2.1.2.1 Key primary sources 36
2.1.2.2 Key objectives of primary research 37
2.1.2.3 Key data from primary sources 37
2.1.2.4 Key primary insights 38
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 40
2.2.2 TOP-DOWN APPROACH 41
2.2.3 DEMAND-SIDE APPROACH 42
2.2.4 VOLUME DATA ANALYSIS 43
2.2.5 PROCEDURE DATA ANALYSIS 43
2.3 DATA TRIANGULATION 46
2.4 MARKET SHARE ANALYSIS 47
2.5 STUDY ASSUMPTIONS 47
2.6 RESEARCH LIMITATIONS 48
2.7 RISK ASSESSMENT 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 53
4.1 ENDOSCOPIC ULTRASOUND MARKET OVERVIEW 53
4.2 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER AND COUNTRY, 2023 54
4.3 ENDOSCOPIC ULTRASOUND MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
4.4 ENDOSCOPIC ULTRASOUND MARKET: REGIONAL MIX 56
4.5 ENDOSCOPIC ULTRASOUND MARKET: DEVELOPED VS. EMERGING ECONOMIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing requirement for endoscopy procedures to diagnose and treat target diseases 58
5.2.1.2 Rising incidence of gastrointestinal disorders and colorectal cancer 59
5.2.1.3 Increased investments, funds, and grants by government bodies and other organizations 60
5.2.1.4 Technological advancements in endoscopic ultrasound devices 61
5.2.2 RESTRAINTS 62
5.2.2.1 High costs of endoscopic ultrasound procedures 62
5.2.2.2 Complications and limitations of endoscopic ultrasound 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 High market growth potential in emerging economies 64
5.2.3.2 Increasing preference for minimally invasive surgeries 65
5.2.4 CHALLENGES 66
5.2.4.1 Increasing number of product recalls 66
5.3 INDUSTRY TRENDS 66
5.3.1 ULTRASOUND CAPSULE ENDOSCOPY 66
5.3.2 ENDOSCOPIC ULTRASOUND-GUIDED SHEAR WAVE ELASTOGRAPHY 67
5.4 VALUE CHAIN ANALYSIS 67
5.5 SUPPLY CHAIN ANALYSIS 68
5.6 TECHNOLOGY ANALYSIS 70
5.6.1 KEY TECHNOLOGIES 70
5.6.1.1 Contrast-enhanced endoscopic ultrasound 70
5.6.1.2 Lumen-apposing metal stents 70
5.6.2 COMPLEMENTARY TECHNOLOGIES 71
5.6.2.1 Elastography 71
5.7 PORTER’S FIVE FORCES ANALYSIS 71
5.7.1 THREAT OF NEW ENTRANTS 72
5.7.2 THREAT OF SUBSTITUTES 72
5.7.3 BARGAINING POWER OF SUPPLIERS 72
5.7.4 BARGAINING POWER OF BUYERS 73
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 73
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 73
5.8.2 KEY BUYING CRITERIA 74
5.9 REGULATORY ANALYSIS 74
5.9.1 REGULATORY FRAMEWORK 75
5.9.1.1 North America 75
5.9.1.1.1 US 75
5.9.1.1.2 Canada 75
5.9.1.2 Europe 75
5.9.1.2.1 Germany 76
5.9.1.2.2 France 76
5.9.1.2.3 UK 76
5.9.1.2.4 Italy 77
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
5.10 PRICING ANALYSIS 79
5.10.1 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021–2023 79
5.10.2 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021–2023 81
5.11 ECOSYSTEM ANALYSIS 82
5.11.1 ROLE IN ECOSYSTEM 83
5.12 PATENT ANALYSIS 84
5.12.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASOUND 84
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 85
5.13 TRADE ANALYSIS 87
5.13.1 IMPORT DATA FOR HS CODE 901890 87
5.13.2 EXPORT DATA FOR HS CODE 901890 88
5.14 KEY CONFERENCES & EVENTS, 2025–2026 88
5.15 UNMET NEEDS/END-USER EXPECTATIONS 90
5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASOUND MARKET 91
5.17 CASE STUDY ANALYSIS 92
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93
5.19 ADJACENT MARKETS 94
5.20 INVESTMENT & FUNDING SCENARIO 94
6 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT 95
6.1 INTRODUCTION 96
6.2 ENDOSCOPES 96
6.2.1 RADIAL ENDOSCOPES 98
6.2.1.1 High image quality, improved penetration depth,
and excellent maneuverability to propel segment growth 98
6.2.2 LINEAR ENDOSCOPES 99
6.2.2.1 Improved real-time targeting of lesions and better clinical management to aid segment growth 99
6.3 ULTRASOUND PROCESSORS 101
6.3.1 ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING 101
6.4 ULTRASOUND PROBES 103
6.4.1 CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH 103
6.5 ULTRASOUND NEEDLES 104
6.5.1 FINE NEEDLE ASPIRATION 106
6.5.1.1 Superior accuracy and effectiveness in staging cancer to fuel segment growth 106
6.5.2 FINE NEEDLE BIOPSIES 107
6.5.2.1 Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth 107
6.5.3 OTHER ULTRASOUND NEEDLES 108
6.6 ACCESSORIES 109
6.6.1 INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET 109
7 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE 111
7.1 INTRODUCTION 112
7.2 DIAGNOSTICS 112
7.2.1 RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH 112
7.3 THERAPEUTICS 113
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH 113
8 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION 115
8.1 INTRODUCTION 116
8.2 ONCOLOGY 116
8.2.1 UPPER GASTROINTESTINAL ONCOLOGY 118
8.2.1.1 Increasing incidence of esophageal and gastric cancers to drive segment 118
8.2.2 LOWER GASTROINTESTINAL ONCOLOGY 119
8.2.2.1 High prevalence of colorectal cancer to support segment growth 119
8.3 GASTROINTESTINAL DISORDERS 120
8.3.1 PANCREATIC DISORDERS 122
8.3.1.1 Rising burden of chronic pancreatic diseases to aid segment growth 122
8.3.2 OTHER GASTROINTESTINAL DISORDERS 124
8.4 OTHER APPLICATIONS 125
9 ENDOSCOPIC ULTRASOUND MARKET, BY END USER 127
9.1 INTRODUCTION 128
9.2 HOSPITALS 128
9.2.1 INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH 128
9.3 AMBULATORY SURGERY CENTERS 129
9.3.1 COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH 129
9.4 OTHER END USERS 131
10 ENDOSCOPIC ULTRASOUND MARKET, BY REGION 133
10.1 INTRODUCTION 134
10.2 NORTH AMERICA 135
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 136
10.2.2 US 140
10.2.2.1 US to dominate North American endoscopic ultrasound market during forecast period 140
10.2.3 CANADA 144
10.2.3.1 Rising incidence of cancer and increasing focus on early disease detection to propel market growth 144
10.3 EUROPE 148
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 148
10.3.2 GERMANY 151
10.3.2.1 Increased healthcare spending and favorable research initiatives to spur market growth 151
10.3.3 UK 155
10.3.3.1 High government healthcare funding to support market growth 155
10.3.4 FRANCE 158
10.3.4.1 Advancements in healthcare and favorable national health insurance to fuel market growth 158
10.3.5 ITALY 161
10.3.5.1 Rising geriatric population and increasing focus on cancer care to propel market growth 161
10.3.6 SPAIN 165
10.3.6.1 High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth 165
10.3.7 REST OF EUROPE 168
10.4 ASIA PACIFIC 171
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 171
10.4.2 JAPAN 176
10.4.2.1 Favorable government health insurance schemes and high geriatric population to aid market growth 176
10.4.3 CHINA 179
10.4.3.1 Large patient pool and high obesity rates to drive market 179
10.4.4 INDIA 183
10.4.4.1 Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth 183
10.4.5 SOUTH KOREA 186
10.4.5.1 High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth 186
10.4.6 AUSTRALIA 190
10.4.6.1 Increased patient volume and favorable government initiatives to drive market 190
10.4.7 REST OF ASIA PACIFIC 193
10.5 LATIN AMERICA 196
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 196
10.5.2 BRAZIL 200
10.5.2.1 High risk of chronic diseases among geriatric population to propel market growth 200
10.5.3 MEXICO 203
10.5.3.1 Improved healthcare infrastructure and increased cancer awareness to augment market growth 203
10.5.4 REST OF LATIN AMERICA 207
10.6 MIDDLE EAST & AFRICA 210
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 210
10.6.2 GCC COUNTRIES 214
10.6.2.1 Increasing healthcare infrastructure development and investment to support market growth 214
10.6.3 REST OF MIDDLE EAST AND AFRICA 217
11 COMPETITIVE LANDSCAPE 221
11.1 INTRODUCTION 221
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 221
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET 221
11.3 REVENUE ANALYSIS, 2019–2023 223
11.4 MARKET SHARE ANALYSIS, 2023 224
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 226
11.5.1 STARS 226
11.5.2 EMERGING LEADERS 226
11.5.3 PERVASIVE PLAYERS 226
11.5.4 PARTICIPANTS 226
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 228
11.5.5.1 Company footprint 228
11.5.5.2 Region footprint 229
11.5.5.3 Product footprint 230
11.5.5.4 Type footprint 232
11.5.5.5 Application footprint 233
11.5.5.6 End-user footprint 234
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 235
11.6.1 PROGRESSIVE COMPANIES 235
11.6.2 RESPONSIVE COMPANIES 235
11.6.3 DYNAMIC COMPANIES 235
11.6.4 STARTING BLOCKS 235
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 237
11.6.5.1 Detailed list of key startups/SMEs 237
11.6.5.2 Competitive benchmarking of key startups/SMEs 238
11.7 COMPANY VALUATION & FINANCIAL METRICS 239
11.8 BRAND/PRODUCT COMPARISON 240
11.9 R&D ASSESSMENT OF KEY PLAYERS 241
11.10 COMPETITIVE SCENARIO 242
11.10.1 PRODUCT LAUNCHES & APPROVALS 242
11.10.2 EXPANSIONS 243
11.10.3 DEALS 244
11.10.4 OTHER DEVELOPMENTS 245
12 COMPANY PROFILES 246
12.1 KEY PLAYERS 246
12.1.1 OLYMPUS CORPORATION 246
12.1.1.1 Business overview 246
12.1.1.2 Products offered 248
12.1.1.3 Recent developments 249
12.1.1.3.1 Product launches & approvals 249
12.1.1.3.2 Deals 250
12.1.1.3.3 Expansions 251
12.1.1.4 MnM view 252
12.1.1.4.1 Key strengths 252
12.1.1.4.2 Strategic choices 252
12.1.1.4.3 Weaknesses & competitive threats 252
12.1.2 MEDTRONIC 253
12.1.2.1 Business overview 253
12.1.2.2 Products offered 254
12.1.2.3 Recent developments 255
12.1.2.3.1 Product approvals 255
12.1.2.3.2 Deals 255
12.1.2.3.3 Expansions 256
12.1.2.4 MnM view 256
12.1.2.4.1 Key strengths 256
12.1.2.4.2 Strategic choices 256
12.1.2.4.3 Weaknesses & competitive threats 256
12.1.3 FUJIFILM HOLDINGS CORPORATION 257
12.1.3.1 Business overview 257
12.1.3.2 Products offered 259
12.1.3.3 Recent developments 260
12.1.3.3.1 Product launches & approvals 260
12.1.3.3.2 Deals 261
12.1.3.3.3 Other developments 261
12.1.3.4 MnM view 262
12.1.3.4.1 Key strengths 262
12.1.3.4.2 Strategic choices 262
12.1.3.4.3 Weaknesses & competitive threats 262
12.1.4 BOSTON SCIENTIFIC CORPORATION 263
12.1.4.1 Business overview 263
12.1.4.2 Products offered 264
12.1.4.3 Recent developments 265
12.1.4.3.1 Product approvals 265
12.1.4.3.2 Deals 265
12.1.4.4 MnM view 266
12.1.4.4.1 Key strengths 266
12.1.4.4.2 Strategic choices 266
12.1.4.4.3 Weaknesses & competitive threats 266
12.1.5 PENTAX MEDICAL 267
12.1.5.1 Business overview 267
12.1.5.2 Products offered 267
12.1.5.3 Recent developments 269
12.1.5.3.1 Product launches & approvals 269
12.1.5.3.2 Deals 270
12.1.5.4 MnM view 270
12.1.5.4.1 Key strengths 270
12.1.5.4.2 Strategic choices 270
12.1.5.4.3 Weaknesses & competitive threats 270
12.1.6 STERIS 271
12.1.6.1 Business overview 271
12.1.6.2 Products offered 273
12.1.6.3 Recent developments 273
12.1.6.3.1 Deals 273
12.1.6.3.2 Expansions 274
12.1.7 CONMED CORPORATION 275
12.1.7.1 Business overview 275
12.1.7.2 Products offered 276
12.1.7.3 Recent developments 277
12.1.7.3.1 Deals 277
12.1.8 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 278
12.1.8.1 Business overview 278
12.1.8.2 Products offered 279
12.1.8.3 Recent developments 279
12.1.8.3.1 Product approvals 279
12.1.9 CANON MEDICAL SYSTEMS CORPORATION 280
12.1.9.1 Business overview 280
12.1.9.2 Products offered 281
12.1.9.3 Recent developments 282
12.1.9.3.1 Deals 282
12.1.10 COOK 283
12.1.10.1 Business overview 283
12.1.10.2 Products offered 283
12.1.10.3 Recent developments 284
12.1.10.3.1 Product launches 284
12.1.10.3.2 Deals 284
12.1.10.3.3 Expansions 285
12.2 OTHER PLAYERS 286
12.2.1 HUACO HEALTHCARE TECHNOLOGIES CO., LTD. 286
12.2.2 SONOSCAPE MEDICAL CORP. 287
12.2.3 ENDOSOUND, INC. 288
12.2.4 LIMACA-MEDICAL 288
12.2.5 BEIJING ZKSK TECHNOLOGY CO., LTD. 289
12.2.6 KAIGEN PHARMA CO., LTD. 290
12.2.7 PIOLAX MEDICAL DEVICES, INC. 291
12.2.8 MICRO-TECH ENDOSCOPY 291
12.2.9 SHAILI ENDOSCOPY 292
12.2.10 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD. 293
12.2.11 ENDO-FLEX GMBH 294
12.2.12 ACE MEDICAL DEVICES PVT. LTD. 295
12.2.13 MEDI-GLOBE GMBH 295
12.2.14 MEDORAH MEDITEK PVT. LTD. 296
12.2.15 INNERMEDICAL CO., LTD. 297
13 APPENDIX 298
13.1 DISCUSSION GUIDE 298
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 303
13.3 CUSTOMIZATION OPTIONS 305
13.4 RELATED REPORTS 305
13.5 AUTHOR DETAILS 306
LIST OF TABLES
TABLE 1 ENDOSCOPIC ULTRASOUND MARKET: INCLUSIONS & EXCLUSIONS 31
TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 32
TABLE 3 ENDOSCOPIC ULTRASOUND MARKET: STUDY ASSUMPTIONS 47
TABLE 4 ENDOSCOPIC ULTRASOUND MARKET: RISK ASSESSMENT 48
TABLE 5 US: ESTIMATED NUMBER OF NEW COLORECTAL CANCER CASES,
BY AGE AND SEX (2023) 60
TABLE 6 MAJOR DEVELOPMENTS IN FUNDING ORGANIZATIONS,
JANUARY 2021–DECEMBER 2024 60
TABLE 7 GENERIC DIAGNOSTIC ENDOSCOPIC ULTRASOUND PROCEDURE COST IN ALBERTA, CANADA (2023) 62
TABLE 8 COST OF RECTAL ENDOSCOPIC ULTRASOUND FOR US (2023) 62
TABLE 9 COMPANY EXPANSIONS IN EMERGING ECONOMIES 65
TABLE 10 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2020–2022 66
TABLE 11 ENDOSCOPIC ULTRASOUND MARKET: PORTER’S FIVE FORCES 72
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 73
TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS 74
TABLE 14 REGULATORY STANDARDS/APPROVALS REQUIRED FOR ENDOSCOPY, BY COUNTRY 77
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS,
BY KEY PLAYER, 2021–2023 79
TABLE 19 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS,
BY REGION, 2021–2023 81
TABLE 20 ENDOSCOPIC ULTRASOUND MARKET: ROLE IN ECOSYSTEM 83
TABLE 21 ENDOSCOPIC ULTRASOUND MARKET: LIST OF PATENTS/PATENT APPLICATIONS, JANUARY 2021–DECEMBER 2024 86
TABLE 22 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2019–2023 (USD THOUSAND) 87
TABLE 23 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2019–2023 (USD THOUSAND) 88
TABLE 24 ENDOSCOPIC ULTRASOUND MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 88
TABLE 25 ENDOSCOPIC ULTRASOUND MARKET: UNMET NEEDS/END-USER EXPECTATIONS 90
TABLE 26 DEVELOPMENT OF ADVANCED SYSTEMS BY OLYMPUS CORPORATION
TO ENHANCE MANAGEMENT OF GASTROINTESTINAL AND
PANCREATICOBILIARY DISEASES 92
TABLE 27 USE OF SLIM LINEAR ECHOENDOSCOPE IN EUS PROCEDURES
BY PENTAX MEDICAL 92
TABLE 28 USE OF SHARKCORE FNB NEEDLE BY MEDTRONIC TO FACILITATE DIAGNOSTIC YIELD IN EUS-GUIDED BIOPSIES 93
TABLE 29 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 96
TABLE 30 ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 31 ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 98
TABLE 32 RADIAL ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 33 LINEAR ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 34 ENDOSCOPIC ULTRASOUND PROCESSORS MARKET,
BY REGION, 2022–2029 (THOUSAND UNITS) 101
TABLE 35 ENDOSCOPIC ULTRASOUND PROCESSORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 36 ENDOSCOPIC ULTRASOUND PROBES MARKET,
BY REGION, 2022–2029 (THOUSAND UNITS) 103
TABLE 37 ENDOSCOPIC ULTRASOUND PROBES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 38 ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 39 ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 105
TABLE 40 FINE NEEDLE ASPIRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 41 FINE NEEDLE BIOPSIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 42 OTHER ULTRASOUND NEEDLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 109
TABLE 43 ENDOSCOPIC ULTRASOUND MARKET FOR ACCESSORIES,
BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 44 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE 2022–2029 (USD MILLION) 112
TABLE 45 ENDOSCOPIC ULTRASOUND MARKET FOR DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 46 ENDOSCOPIC ULTRASOUND MARKET FOR THERAPEUTICS,
BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 47 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION 2022–2029 (USD MILLION) 116
TABLE 48 ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 49 ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 118
TABLE 50 UPPER GASTROINTESTINAL ONCOLOGY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 51 LOWER GASTROINTESTINAL ONCOLOGY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 52 ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS,
BY TYPE, 2022–2029 (USD MILLION) 121
TABLE 53 NUMBER OF PROCEDURES FOR GASTROINTESTINAL DISORDERS,
BY REGION, 2023 (THOUSAND/MILLION) 121
TABLE 54 ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 55 PANCREATIC DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 56 OTHER GASTROINTESTINAL DISORDERS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 57 ENDOSCOPIC ULTRASOUND MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 58 ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 128
TABLE 59 ENDOSCOPIC ULTRASOUND MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 60 ENDOSCOPIC ULTRASOUND MARKET FOR AMBULATORY SURGERY CENTERS,
BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 61 ENDOSCOPIC ULTRASOUND MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 62 ENDOSCOPIC ULTRASOUND MARKET, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 63 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 64 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 137
TABLE 65 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 137
TABLE 66 NORTH AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 67 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 68 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 138
TABLE 69 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 139
TABLE 70 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 139
TABLE 71 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 139
TABLE 72 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024 140
TABLE 73 US: KEY MACROINDICATORS 141
TABLE 74 US: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 141
TABLE 75 US: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 141
TABLE 76 US: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 142
TABLE 77 US: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 142
TABLE 78 US: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 142
TABLE 79 US: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 80 US: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS,
BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 81 US: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 143
TABLE 82 CANADA: KEY MACROINDICATORS 145
TABLE 83 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 145
TABLE 84 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 145
TABLE 85 CANADA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 146
TABLE 86 CANADA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 146
TABLE 87 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 146
TABLE 88 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 147
TABLE 89 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 147
TABLE 90 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 147
TABLE 91 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 148
TABLE 92 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 149
TABLE 93 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 94 EUROPE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 95 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE,
2022–2029 (USD MILLION) 150
TABLE 96 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 150
TABLE 97 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 98 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 99 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 151
TABLE 100 GERMANY: KEY MACROINDICATORS 152
TABLE 101 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 152
TABLE 102 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 152
TABLE 103 GERMANY: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 104 GERMANY: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 105 GERMANY: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 153
TABLE 106 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 107 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 108 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 154
TABLE 109 UK: KEY MACROINDICATORS 155
TABLE 110 UK: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 155
TABLE 111 UK: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 156
TABLE 112 UK: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 156
TABLE 113 UK: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 156
TABLE 114 UK: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 157
TABLE 115 UK: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 157
TABLE 116 UK: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS,
BY TYPE, 2022–2029 (USD MILLION) 157
TABLE 117 UK: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 158
TABLE 118 FRANCE: KEY MACROINDICATORS 158
TABLE 119 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 159
TABLE 120 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 159
TABLE 121 FRANCE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 159
TABLE 122 FRANCE: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 160
TABLE 123 FRANCE: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 160
TABLE 124 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 160
TABLE 125 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 126 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 161
TABLE 127 ITALY: KEY MACROINDICATORS 162
TABLE 128 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 162
TABLE 129 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 162
TABLE 130 ITALY: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 163
TABLE 131 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 163
TABLE 132 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 163
TABLE 133 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 134 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 135 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 164
TABLE 136 SPAIN: KEY MACROINDICATORS 165
TABLE 137 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 165
TABLE 138 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 139 SPAIN: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 140 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 141 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 167
TABLE 142 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 143 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 144 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 168
TABLE 145 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 168
TABLE 146 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 147 REST OF EUROPE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 148 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 149 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 170
TABLE 150 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 151 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 152 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 171
TABLE 153 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 154 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 173
TABLE 155 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 156 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 157 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 158 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 174
TABLE 159 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 160 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 161 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 175
TABLE 162 JAPAN: KEY MACROINDICATORS 176
TABLE 163 JAPAN: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 177
TABLE 164 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 165 JAPAN: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 166 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 167 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 178
TABLE 168 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 169 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 170 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 179
TABLE 171 CHINA: KEY MACROINDICATORS 180
TABLE 172 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 180
TABLE 173 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 174 CHINA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 175 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 176 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 181
TABLE 177 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 178 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 179 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 182
TABLE 180 INDIA: KEY MACROINDICATORS 183
TABLE 181 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 184
TABLE 182 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 183 INDIA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 184 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 185 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 185
TABLE 186 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 187 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 188 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 186
TABLE 189 SOUTH KOREA: KEY MACROINDICATORS 187
TABLE 190 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 187
TABLE 191 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 192 SOUTH KOREA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 193 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 194 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 188
TABLE 195 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 196 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 197 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 189
TABLE 198 AUSTRALIA: KEY MACROINDICATORS 190
TABLE 199 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 190
TABLE 200 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 201 AUSTRALIA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 202 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 203 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 192
TABLE 204 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 205 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 206 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2022–2029 (USD MILLION) 193
TABLE 207 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 193
TABLE 208 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 209 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 210 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 211 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 195
TABLE 212 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 213 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 214 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 196
TABLE 215 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 216 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 197
TABLE 217 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 218 LATIN AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 219 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 220 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 198
TABLE 221 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 222 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 223 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 199
TABLE 224 BRAZIL: KEY MACROINDICATORS 200
TABLE 225 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 201
TABLE 226 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 227 BRAZIL: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 228 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 229 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 202
TABLE 230 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 231 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 232 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 203
TABLE 233 MEXICO: KEY MACROINDICATORS 204
TABLE 234 MEXICO: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 204
TABLE 235 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 236 MEXICO: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 237 MEXICO: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 238 MEXICO: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 205
TABLE 239 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 240 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 241 MEXICO: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 206
TABLE 242 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 207
TABLE 243 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 244 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 245 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 246 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 208
TABLE 247 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 248 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 249 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 209
TABLE 250 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY REGION, 2022–2029 (USD MILLION) 211
TABLE 251 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 211
TABLE 252 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 253 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 254 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 255 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 212
TABLE 256 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 257 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 258 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 213
TABLE 259 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 214
TABLE 260 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES,
BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 261 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND NEEDLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 262 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 263 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 216
TABLE 264 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY,
BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 265 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 266 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 217
TABLE 267 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 218
TABLE 268 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 269 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 270 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 271 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 219
TABLE 272 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET
FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 273 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 274 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET,
BY END USER, 2022–2029 (USD MILLION) 220
TABLE 275 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET 221
TABLE 276 ENDOSCOPIC ULTRASOUND MARKET: DEGREE OF COMPETITION 225
TABLE 277 ENDOSCOPIC ULTRASOUND MARKET: REGION FOOTPRINT 229
TABLE 278 ENDOSCOPIC ULTRASOUND MARKET: PRODUCT FOOTPRINT 230
TABLE 279 ENDOSCOPIC ULTRASOUND MARKET: TYPE FOOTPRINT 232
TABLE 280 ENDOSCOPIC ULTRASOUND MARKET: APPLICATION FOOTPRINT 233
TABLE 281 ENDOSCOPIC ULTRASOUND MARKET: END-USER FOOTPRINT 234
TABLE 282 ENDOSCOPIC ULTRASOUND MARKET: DETAILED LIST OF KEY STARTUPS/SMES 237
TABLE 283 ENDOSCOPIC ULTRASOUND MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 238
TABLE 284 ENDOSCOPIC ULTRASOUND MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 242
TABLE 285 ENDOSCOPIC ULTRASOUND MARKET: EXPANSIONS,
JANUARY 2021–DECEMBER 2024 243
TABLE 286 ENDOSCOPIC ULTRASOUND MARKET: DEALS, JANUARY 2021–DECEMBER 2024 244
TABLE 288 OLYMPUS CORPORATION: COMPANY OVERVIEW 246
TABLE 289 OLYMPUS CORPORATION: PRODUCTS OFFERED 248
TABLE 290 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–DECEMBER 2024 249
TABLE 291 OLYMPUS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 250
TABLE 292 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024 251
TABLE 293 MEDTRONIC: COMPANY OVERVIEW 253
TABLE 294 MEDTRONIC: PRODUCTS OFFERED 254
TABLE 295 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024 255
TABLE 296 MEDTRONIC: DEALS, JANUARY 2021–DECEMBER 2024 255
TABLE 297 MEDTRONIC: EXPANSIONS, JANUARY 2021–DECEMBER 2024 256
TABLE 298 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 257
TABLE 299 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 259
TABLE 300 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–DECEMBER 2024 260
TABLE 301 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 261
TABLE 302 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021–DECEMBER 2024 261
TABLE 303 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 263
TABLE 304 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 264
TABLE 305 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2024 265
TABLE 306 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 265
TABLE 307 PENTAX MEDICAL: COMPANY OVERVIEW 267
TABLE 308 PENTAX MEDICAL: PRODUCTS OFFERED 267
TABLE 309 PENTAX MEDICAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–DECEMBER 2024 269
TABLE 310 PENTAX MEDICAL: DEALS, JANUARY 2021−DECEMBER 2024 270
TABLE 311 STERIS: COMPANY OVERVIEW 271
TABLE 312 STERIS: PRODUCTS OFFERED 273
TABLE 313 STERIS: DEALS, JANUARY 2021–DECEMBER 2024 273
TABLE 314 STERIS: EXPANSIONS, JANUARY 2021–DECEMBER 2024 274
TABLE 315 CONMED CORPORATION: COMPANY OVERVIEW 275
TABLE 316 CONMED CORPORATION: PRODUCTS OFFERED 276
TABLE 317 CONMED CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 277
TABLE 318 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 278
TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 279
TABLE 320 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2024 279
TABLE 321 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 280
TABLE 322 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 281
TABLE 323 CANON MEDICAL SYSTEMS CORPORATION: DEALS,
JANUARY 2021–DECEMBER 2024 282
TABLE 324 COOK: COMPANY OVERVIEW 283
TABLE 325 COOK: PRODUCTS OFFERED 283
TABLE 326 COOK: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024 284
TABLE 327 COOK: DEALS, JANUARY 2021–DECEMBER 2024 284
TABLE 328 COOK: EXPANSIONS, JANUARY 2021–DECEMBER 2024 285
TABLE 329 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 286
TABLE 330 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW 287
TABLE 331 ENDOSOUND, INC.: COMPANY OVERVIEW 288
TABLE 332 LIMACA-MEDICAL: COMPANY OVERVIEW 288
TABLE 333 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 289
TABLE 334 KAIGEN PHARMA CO., LTD.: COMPANY OVERVIEW 290
TABLE 335 PIOLAX MEDICAL DEVICES, INC.: COMPANY OVERVIEW 291
TABLE 336 MICRO-TECH ENDOSCOPY: COMPANY OVERVIEW 291
TABLE 337 SHAILI ENDOSCOPY: COMPANY OVERVIEW 292
TABLE 338 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 293
TABLE 339 ENDO-FLEX GMBH: COMPANY OVERVIEW 294
TABLE 340 ACE MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW 295
TABLE 341 MEDI-GLOBE GMBH: COMPANY OVERVIEW 295
TABLE 342 MEDORAH MEDITEK PVT. LTD.: COMPANY OVERVIEW 296
TABLE 343 INNERMEDICAL CO., LTD.: COMPANY OVERVIEW 297
LIST OF FIGURES
FIGURE 1 ENDOSCOPIC ULTRASOUND MARKET: MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD 30
FIGURE 2 ENDOSCOPIC ULTRASOUND MARKET: YEARS CONSIDERED 31
FIGURE 3 ENDOSCOPIC ULTRASOUND MARKET: RESEARCH DESIGN 33
FIGURE 4 ENDOSCOPIC ULTRASOUND MARKET: KEY DATA FROM SECONDARY SOURCES 35
FIGURE 5 ENDOSCOPIC ULTRASOUND MARKET: KEY PRIMARY SOURCES 36
FIGURE 6 ENDOSCOPIC ULTRASOUND MARKET: KEY DATA FROM PRIMARY SOURCES 37
FIGURE 7 ENDOSCOPIC ULTRASOUND MARKET: KEY INSIGHTS FROM PRIMARIES 38
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND OTHER PARTICIPANTS 38
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 39
FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 39
FIGURE 11 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 40
FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION (2023) 41
FIGURE 13 ENDOSCOPIC ULTRASOUND MARKET: TOP-DOWN APPROACH 41
FIGURE 14 ENDOSCOPIC ULTRASOUND MARKET: SUPPLY-SIDE ANALYSIS (2023) 43
FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
FIGURE 16 ENDOSCOPIC ULTRASOUND MARKET: CAGR PROJECTIONS 45
FIGURE 17 ENDOSCOPIC ULTRASOUND MARKET: DATA TRIANGULATION 46
FIGURE 18 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 49
FIGURE 19 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 50
FIGURE 20 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 50
FIGURE 21 ENDOSCOPIC ULTRASOUND MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 51
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPIC ULTRASOUND MARKET 52
FIGURE 23 RISING PREVALENCE OF CANCER AND INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET 53
FIGURE 24 CHINA AND HOSPITALS SEGMENTS COMMANDED LARGEST SHARE
IN ASIA PACIFIC ENDOSCOPIC ULTRASOUND MARKET IN 2023 54
FIGURE 25 JAPAN TO WITNESS HIGHEST GROWTH RATE FROM 2024 TO 2029 55
FIGURE 26 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 56
FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING
STUDY PERIOD 56
FIGURE 28 ENDOSCOPIC ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
FIGURE 29 SHARE OF SURGEONS PERFORMING OVER 100 ENDOSCOPIC PROCEDURES PER YEAR GLOBALLY, BY REGION (2024) 58
FIGURE 30 NUMBER OF ANNUAL PLANNED SESSIONS PER INDIVIDUAL IN UK (2021) 59
FIGURE 31 ENDOSCOPIC ULTRASOUND MARKET: VALUE CHAIN ANALYSIS 67
FIGURE 32 ENDOSCOPIC ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS 69
FIGURE 33 ENDOSCOPIC ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS 71
FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE END USERS 73
FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE END USERS 74
FIGURE 36 AVERAGE SELLING PRICE OF ENDOSCOPIC ULTRASOUND PRODUCTS,
BY TYPE (2023) 80
FIGURE 37 ENDOSCOPIC ULTRASOUND MARKET: ECOSYSTEM ANALYSIS 82
FIGURE 38 ENDOSCOPIC ULTRASOUND MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–DECEMBER 2024) 84
FIGURE 39 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPIC ULTRASOUND PATENTS (JANUARY 2014–DECEMBER 2024) 85
FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR ENDOSCOPIC ULTRASOUND PATENTS (JANUARY 2014–DECEMBER 2024) 86
FIGURE 41 ENDOSCOPIC ULTRASOUND MARKET: IMPACT OF AI/GEN AI 91
FIGURE 42 ENDOSCOPIC ULTRASOUND MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93
FIGURE 43 ENDOSCOPIC ULTRASOUND MARKET: ADJACENT MARKETS 94
FIGURE 44 ENDOSCOPIC ULTRASOUND MARKET: INVESTMENT/VENTURE
CAPITAL SCENARIO (2019–2024) 94
FIGURE 45 ENDOSCOPIC ULTRASOUND MARKET REGIONAL SNAPSHOT 134
FIGURE 46 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET SNAPSHOT 136
FIGURE 47 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET SNAPSHOT 172
FIGURE 49 MARKET SHARE ANALYSIS OF PLAYERS IN ENDOSCOPIC ULTRASOUND
MARKET (2023) 224
FIGURE 50 ENDOSCOPIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 227
FIGURE 51 ENDOSCOPIC ULTRASOUND MARKET: COMPANY FOOTPRINT 228
FIGURE 52 ENDOSCOPIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 236
FIGURE 53 EV/EBITDA OF KEY VENDORS 239
FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 239
FIGURE 55 ENDOSCOPIC ULTRASOUND MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 240
FIGURE 56 ENDOSCOPIC ULTRASOUND MARKET: R&D ASSESSMENT OF
KEY PLAYERS (2021–2023) 241
FIGURE 57 OLYMPUS CORPORATION: COMPANY SNAPSHOT 247
FIGURE 58 MEDTRONIC: COMPANY SNAPSHOT 254
FIGURE 59 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 258
FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 264
FIGURE 61 STERIS: COMPANY SNAPSHOT 272
FIGURE 62 CONMED CORPORATION: COMPANY SNAPSHOT 276
FIGURE 63 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT 278
FIGURE 64 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 281
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。
最新調査レポート
- 尿失禁デバイス市場 – 2030年までの世界予測 2025-03-12
- 医療用加湿器市場 – 2029年までの世界予測 2025-03-11
- BOPETフィルム市場 – 2029年までの世界予測 2025-03-11
- 金ナノ粒子市場 – 2029年までの世界予測 2025-03-07
- 沈降シリカ市場 – 2030年までの世界予測 2025-03-07